rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9780826129345

Brain Disabling Treatments in Psychiatry

by
  • ISBN13:

    9780826129345

  • ISBN10:

    082612934X

  • Edition: 2nd
  • Format: Hardcover
  • Copyright: 2007-12-17
  • Publisher: Springer Pub Co

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
  • Write a Review Icon Write a Review
List Price: $92.10 Save up to $31.54
  • Rent Book $60.56
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 24-48 HOURS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

How To: Textbook Rental

Looking to rent a book? Rent Brain Disabling Treatments in Psychiatry [ISBN: 9780826129345] for the semester, quarter, and short term or search our site for other textbooks by Breggin, Peter R.. Renting a textbook can save you up to 90% from the cost of buying.

Summary

Presents scientific research on dangerous behavioral abnormalities and brain dysfunctions produced by most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, and more. Includes a new chapter on safely withdrawing from prescription drugs. For clinicians. Previous edition not cited. DNLM: United States Food and Drug Administration.

Table of Contents

Preface: A Word About Words
Introduction: Confirming the Science Behind the First Edition
The Brain-Disabling, Spellbinding Effects of Psychiatric Drugsp. 1
Deactivation Syndrome (Chemical Lobotomy) Caused by Neurolepticsp. 21
Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depressionp. 43
Severe and Potentially Irreversible Neurological Syndromes (Tardive Dyskinesia and Neuroleptic Malignant Syndrome) Caused by Neurolepticsp. 55
Neuroleptic-Induced Neurotoxicity, Brain Damage, Persistent Cognitive Deficits, Dementia, and Psychosisp. 85
Recent Developments in Antidepressant Label Changesp. 115
Antidepressant-Induced Mental, Behavioral, and Cerebral Abnormalitiesp. 137
Lithium and Other Drugs for Bipolar Disorderp. 193
Electroconvulsive Therapy (ECT) for Depressionp. 217
From Attention-Deficit/Hyperactivity Disorder (ADHD) to Bipolar Disorder: Diagnosing America's Childrenp. 253
Stimulant-Induced Brain Damage, Brain Dysfunction, and Psychiatric Adverse Reactionsp. 283
Antianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcionp. 319
The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH): Drug Company Advocatesp. 347
Drug Company Deceptionsp. 377
How to More Safely Stop Taking Psychiatric Drugsp. 411
Failed Promises, Last Resorts, and Psychotherapyp. 425
Psychiatric Medications by Categoryp. 459
Bibliographyp. 463
Indexp. 527
Table of Contents provided by Blackwell. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program